Swiss National Bank lifted its position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 0.7% in the fourth ...

Supernus Pharmaceuticals (NASDAQ:SUPN – Get Free Report) was downgraded by StockNews.com from a “strong-buy” rating to a “buy ...

Small-cap stocks in the US have been under pressure, with the Russell small cap index falling 10% from its November highs as of January 2025.

Samsung gave Mobile World Congress attendees an arm's-length look at its Project Moohan Android XR headset. Here's what I saw. I’m PCMag’s managing editor for consumer electronics content ...

The company has built a strong presence in the CNS market with well-known products like Qelbree for ADHD, Trokendi XR, and Oxtellar XR for epilepsy, and treatments for Parkinson’s disease such ...

China-based Play for Dream, the company building a Vision Pro-like standalone MR headset, says it expects to adopt Android XR as its standalone operating system. The Play for Dream MR headset has ...

The increase in both periods was primarily due to increases in net sales of Qelbree and GOCOVRI, partially offset by the decline in net product sales of Trokendi XR and Oxtellar XR due to generic ...

Our performance in 2024 underscored our emphasis on growing our core business despite the loss of exclusivity on both Trokendi XR and Oxtellar XR. Total revenues excluding Trokendi XR and Oxtellar ...

Full year 2024 revenues increased 9% to $661.8 million, compared to the same period in 2023; Full year 2024 total revenues excluding Trokendi XR and Oxtellar XR net product sales (non-GAAP ...

Common Anti-Epileptic Drugs. There are several anticonvulsant drugs that are commonly prescribed. Understanding how your ...